查看購物車
  • Simplified Chinese
  • English
封面
市場調查報告書
商品編碼
1722583

2025 年至 2033 年獸醫市場報告（依產品、動物類型、給藥途徑、配銷通路及地區）

Veterinary Medicine Market Report by Product, Animal Type, Route of Administration, Distribution Channel, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球獸藥市場規模達 374 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 604 億美元，2025-2033 年期間的成長率 (CAGR) 為 5.47%。寵物擁有量的增加、診斷和治療技術的重大進步、對牲畜食品安全和疾病控制的需求不斷增加、政府促進動物健康的舉措、該領域的持續研究和開發以及對生產動物和伴侶動物的獸醫護理的需求是推動市場發展的一些主要因素。

獸醫學是醫學科學的一個專門分支，主要關注動物的健康和福祉。它涵蓋各種動物物種的疾病、損傷和紊亂的診斷、治療和預防。它在促進動物健康、福利和公共健康方面發揮著至關重要的作用。獸醫是經過專業訓練的獸醫專業人員，負責為動物提供醫療服務，包括家養寵物、牲畜、野生動物和實驗動物。他們進行全面檢查、診斷測試、開藥、進行手術並提供疫苗接種等預防性護理。獸醫學領域涵蓋多個學科，包括內科、外科、皮膚病學、放射學、病理學和牙科。獸醫與寵物主人、牲畜飼養者、動物園管理員以及動物行業的其他專業人士密切合作，以確保他們照顧的動物的健康。

寵物擁有量的上升趨勢，尤其是在城市地區，正在推動對獸醫藥物的需求。寵物主人擴大尋求獸醫服務來進行常規檢查、接種疫苗和醫療保健需求，從而推動了市場的成長。此外，人們更加重視動物福利和預防性護理，從而提高了對動物藥物重要性的認知。寵物主人和畜牧養殖戶認知到定期看獸醫以確保動物整體健康和福祉的重要性。除此之外，可以透過動物傳播給人類的人畜共通傳染病近年來也受到了廣泛關注。此外，禽流感和新冠肺炎等疾病的爆發凸顯了對有效獸醫藥物預防和控制此類疾病的必要性，從而導致對動物健康的投資增加。除此之外，對肉類、乳製品和其他動物性食品的需求不斷成長，也增加了畜牧業對獸藥的需求。確保農場動物的健康和福祉對於維持食品安全標準和滿足不斷成長的消費者需求至關重要。除此之外，診斷影像、實驗室檢測和外科手術技術等獸醫技術的進步顯著改善了動物疾病的診斷和治療。此外，針對動物健康和福利的政府法規和措施在塑造市場方面發揮著至關重要的作用。

獸醫市場趨勢/促進因素：

寵物擁有量增加

寵物擁有量的增加趨勢是市場的一個重要動力。隨著越來越多的人選擇飼養寵物，獸醫服務的需求也隨之增加。寵物主人越來越意識到定期進行獸醫護理的重要性，以確保他們毛茸茸的伙伴的健康和福祉。他們尋求預防措施，例如接種疫苗、定期檢查以及治療跳蚤、蜱蟲和牙齒問題等常見疾病。對獸醫服務日益成長的需求為專門從事獸醫的診所、醫院和製藥公司創造了機會。此外，寵物主人與動物之間的情感紐帶促使他們願意投資寵物的醫療保健，從而進一步促進市場成長。

技術進步

技術進步徹底改變了獸醫領域，推動了市場成長。數位放射成像和超音波等診斷成像的創新使得診斷更加準確和及時。先進的實驗室檢測方法可以更快、更準確地識別疾病。包括微創手術和雷射手術在內的手術技術改善了患者的治療效果並縮短了恢復時間。這些技術進步不僅提高了護理質量，而且增加了對獸醫服務的需求。採用這些技術的獸醫診所獲得了競爭優勢，並吸引了更多尋求最先進動物護理的客戶。

畜牧業生產與食品安全

畜牧生產對獸醫的需求源自於確保動物健康、福利和食品安全的需求。隨著全球人口的成長和肉類消費的增加，畜牧農民面臨滿足動物性食品需求的挑戰。它在維持牲畜健康和生產力方面發揮著至關重要的作用。定期的獸醫護理、疾病預防計劃和適當的管理實踐有助於提高產品品質並降低食源性疾病的風險。消費者對食品安全和動物道德待遇的擔憂進一步強調了畜牧業對強力的獸醫保健的必要性。因此，對獸醫和動物健康管理的投資持續成長，支持了市場的擴張。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球獸醫市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品

  • 藥物
    • 關鍵部分
      • 抗感染
      • 消炎劑
      • 殺寄生蟲劑
  • 疫苗
    • 關鍵部分
      • 去活化疫苗
      • 減毒疫苗
      • 重組疫苗
  • 藥物飼料添加劑
    • 關鍵部分
      • 胺基酸
      • 抗生素

第7章：市場區隔：依動物類型

  • 生產
  • 伴侶

第8章：市場區隔：依行政途徑

  • 口服
  • 腸外
  • 外用

第9章：市場區隔：按配銷通路

  • 獸醫醫院和診所
  • 即時檢驗/內部檢驗
  • 其他

第10章：市場細分：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第 15 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Archer-Daniels-Midland Company
    • Boehringer Ingelheim GmbH
    • Cargill Incorporated
    • Ceva Sante Animale
    • Dechra Pharmaceuticals PLC
    • Elanco Animal Health Incorporated
    • Evonik Industries AG
    • Merck & Co. Inc.
    • Neogen Corporation
    • Vetoquinol SA
    • Virbac
    • Zoetis Inc.
Product Code: SR112025A5627

The global veterinary medicine market size reached USD 37.4 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 60.4 Billion by 2033, exhibiting a growth rate (CAGR) of 5.47% during 2025-2033. The increasing pet ownership, significant technological advancements in diagnostics and treatments, rising need for food safety and disease control in livestock, government initiatives promoting animal health, and ongoing research and development in the field and the demand for veterinary care in both production and companion animals are some of the major factors propelling the market.

Veterinary medicine is a specialized branch of medical science that focuses on the health and well-being of animals. It encompasses the diagnosis, treatment, and prevention of diseases, injuries, and disorders in various animal species. It plays a crucial role in promoting animal health, welfare, and public health. Veterinarians, trained professionals in veterinary medicine, are responsible for providing medical care to animals, including domestic pets, livestock, wildlife, and laboratory animals. They conduct thorough examinations, perform diagnostic tests, prescribe medications, perform surgeries, and provide preventive care such as vaccinations. The field of veterinary medicine encompasses various disciplines, including internal medicine, surgery, dermatology, radiology, pathology, and dentistry. Veterinarians work closely with pet owners, livestock farmers, zookeepers, and other professionals in the animal industry to ensure the well-being of animals under their care.

The rising trend of pet ownership, particularly in urban areas, is driving the demand for veterinary medicine. Pet owners are increasingly seeking veterinary services for routine check-ups, vaccinations, and healthcare needs, thus fueling the growth of the market. Additionally, there is a greater emphasis on animal welfare and preventive care, leading to increased awareness regarding the importance of medicine for animals. Pet owners and livestock farmers are recognizing the significance of regular veterinary visits to ensure the overall health and well-being of their animals. Other than this, zoonotic diseases, which can be transmitted from animals to humans, have gained significant attention in recent years. Furthermore, the outbreak of diseases like avian influenza and COVID-19 have highlighted the need for effective veterinary medicine to prevent and control such diseases, leading to increased investments in animal health. Besides this, the growing demand for meat, dairy products, and other animal-derived food products has increased the need for veterinary medicine in livestock production. Ensuring the health and well-being of farm animals is crucial for maintaining food safety standards and meeting the rising consumer demand. Besides this, advancements in veterinary technology, such as diagnostic imaging, laboratory testing, and surgical techniques, have significantly improved the diagnosis and treatment of animal diseases. Moreover, government regulations and initiatives aimed at animal health and welfare play a vital role in shaping the market.

Veterinary Medicine Market Trends/Drivers:

Increasing pet ownership

The increasing trend of pet ownership is a significant driver of the market. As more people choose to have pets, the demand for veterinary services rises accordingly. Pet owners are increasingly aware of the importance of regular veterinary care to ensure the health and well-being of their furry companions. They seek preventive measures such as vaccinations, regular check-ups, and treatments for common conditions like fleas, ticks, and dental problems. This growing demand for veterinary services creates opportunities for clinics, hospitals, and pharmaceutical companies specializing in veterinary medicine. Additionally, the emotional bond between pet owners and their animals drives the willingness to invest in their healthcare, leading to further market growth.

Technological advancements

Technological advancements have revolutionized the field of veterinary medicine, driving market growth. Innovations in diagnostic imaging, such as digital radiography and ultrasound, enable more accurate and timely diagnoses. Advanced laboratory testing methods allow for quicker and more precise identification of diseases. Surgical techniques, including minimally invasive procedures and laser surgery, have improved patient outcomes and reduced recovery times. These technological advancements not only enhance the quality of care but also increase the demand for veterinary services. Veterinary practices that adopt these technologies gain a competitive edge and attract a larger client base seeking state-of-the-art care for their animals.

Livestock production and food safety

The demand for veterinary medicine in livestock production is driven by the need to ensure animal health, welfare, and food safety. With the increasing global population and rising meat consumption, livestock farmers face the challenge of meeting the demand for animal-derived food products. It plays a crucial role in maintaining the health and productivity of livestock. Regular veterinary care, disease prevention programs, and proper management practices contribute to higher-quality products and reduce the risk of foodborne illnesses. Consumer concerns regarding food safety and the ethical treatment of animals further emphasize the need for robust veterinary healthcare in the livestock industry. As a result, investments in veterinary medicine and animal health management continue to grow, supporting the expansion of the market.

Veterinary Medicine Industry Segmentation:

Breakup by Product:

  • Drugs
  • Anti-infective
  • Anti-inflammatory
  • Parasiticide
  • Vaccines
  • Inactivated Vaccines
  • Attenuated Vaccines
  • Recombinant Vaccines
  • Medicated Feed Additives
  • Amino Acids
  • Antibiotics

Drugs play a crucial role in the treatment and management of animal diseases and conditions. Veterinary drugs include a wide range of pharmaceutical products such as antibiotics, anti-inflammatory drugs, antiparasitics, analgesics, and hormonal therapies. These drugs are specifically formulated and approved for use in animals to address various health issues. The market for veterinary drugs is driven by the need for effective treatment options, advancements in drug development, and the growing prevalence of animal diseases.

Vaccines stimulate an immune response in animals, providing protection against specific diseases. Veterinary vaccines help prevent the spread of infectious diseases and reduce the severity of outbreaks in animals. They are used in both companion animals and livestock, contributing to the overall health and well-being of the animal population. The demand for veterinary vaccines is driven by increased awareness of preventive healthcare, government regulations promoting vaccination programs, and the focus on disease control in animal populations.

Medicated feed additives are substances added to animal feed to deliver specific medications or nutritional supplements. These additives can contain drugs, vitamins, minerals, or other bioactive compounds to improve animal health, enhance growth performance, or prevent and control diseases. Medicated feed additives are commonly used in livestock production, where they contribute to optimized feed efficiency, disease prevention, and overall animal well-being. The market for medicated feed additives is driven by the demand for improved feed quality, the need for efficient disease prevention in large-scale farming, and the emphasis on maximizing productivity in the livestock industry.

Breakup by Animal Type:

  • Production
  • Companion

Production holds the largest share in the market

The market for production animals encompasses livestock and poultry, including cattle, swine, poultry, sheep, and fish. These animals are primarily raised for meat, milk, eggs, and other animal-derived products. The veterinary care for production animals focuses on disease prevention, herd health management, reproductive health, and nutrition. The market for production animals is driven by the increasing global demand for animal protein, advancements in livestock farming practices, the need to ensure food safety, and the emphasis on sustainable and efficient production methods.

The market for companion animals includes domestic pets such as dogs, cats, and exotic pets like birds, reptiles, and small mammals. Companion animal care encompasses a wide range of veterinary services, including preventive care, vaccinations, routine check-ups, dental care, and treatment for various health conditions. The market for companion animals is driven by the growing pet ownership trends, increased awareness of pet health and well-being, the emotional bond between pet owners and their animals, and the demand for high-quality veterinary care, diagnostics, medications, and pet products. The focus on pet health and the willingness to invest in their care contribute to the growth of this segment of the market.

Breakup by Route of Administration:

  • Oral
  • Parenteral
  • Topical

Parenteral dominates the market

Oral administration refers to the delivery of veterinary medications or treatments through the oral route, typically in the form of tablets, capsules, liquids, or feed additives. Oral administration is commonly used in veterinary medicine due to its convenience and ease of use. It allows for controlled dosing, long-lasting effects, and can be administered directly by the animal owner or mixed with food. The market for oral administration products in veterinary medicine is driven by the wide range of oral medications available, the preference for non-invasive administration methods, and the need for medications that can be easily administered to animals at home or on farms.

Parenteral administration involves the delivery of veterinary medications or treatments through routes other than the digestive tract, such as injections (intravenous, intramuscular, subcutaneous), infusions, or implantations. Parenteral administration allows for rapid absorption and immediate effect, making it suitable for emergencies, critical conditions, or situations where precise dosing is required. The market for parenteral administration products in veterinary medicine is driven by the need for fast-acting medications, the ability to administer drugs in a controlled and accurate manner, and the demand for injectable vaccines, antibiotics, anesthetics, and other treatments in both production and companion animals.

Topical administration involves the application of veterinary medications or treatments directly to the skin or mucous membranes of animals. This can include ointments, creams, sprays, powders, or spot-on treatments. Topical administration is commonly used for localized treatment of skin conditions, external parasites, wound care, or eye and ear ailments. It offers localized therapeutic effects, ease of application, and reduced systemic side effects. The market for topical administration products in veterinary medicine is driven by the demand for dermatological treatments, flea and tick control products, wound management solutions, and other topical medications for both companion and production animals.

Breakup by Distribution Channel:

  • Veterinary Hospitals and Clinics
  • Point-of-Care Testing/In-house Testing
  • Others

Veterinary hospitals and clinics represent the largest distribution channel

Veterinary hospitals and clinics serve as primary points of care for animals, providing a wide range of veterinary services, including examinations, diagnostics, treatments, surgeries, and preventive care. They have well-equipped laboratories, pharmacy services, and access to a variety of veterinary medications and products. Veterinary hospitals and clinics play a vital role in the distribution of prescription medications, specialized diets, and other veterinary products. They often have established relationships with pharmaceutical companies and distributors to ensure the availability of a diverse range of veterinary medications and supplies.

Point-of-care testing, also known as in-house testing, refers to diagnostic tests conducted on-site at veterinary clinics or hospitals. These tests allow for rapid and immediate results, enabling veterinarians to make timely treatment decisions. Point-of-care testing encompasses various diagnostic methods, including blood tests, urine tests, imaging technologies, and molecular diagnostics. The market for point-of-care testing is driven by the increasing demand for quick and accurate diagnoses, convenience, and the ability to provide immediate care to animals. Veterinary clinics and hospitals invest in point-of-care testing equipment and kits to enhance their diagnostic capabilities and offer comprehensive veterinary services in a timely manner.

Breakup by Region:

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Others
  • Latin America
  • Brazil
  • Mexico
  • Others
  • Middle East and Africa

North America exhibits a clear dominance in the market

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for veterinary medicines.

North America comprises the United States and Canada, which have well-established veterinary healthcare systems and a large population of both companion and production animals. The market in North America is driven by factors such as the increasing pet ownership, rising demand for quality animal healthcare, advancements in veterinary technology, and a strong focus on animal welfare. The region has a well-developed network of veterinary hospitals, clinics, and specialized veterinary care providers. Additionally, there is significant investment in research and development, leading to the introduction of new veterinary drugs, vaccines, and diagnostic tools. North America also has stringent regulations regarding animal health and welfare, driving the demand for veterinary products and services.

Europe represents a substantial market for veterinary medicine, encompassing countries such as the United Kingdom, Germany, France, and Italy. The market in Europe is driven by factors such as a large population of companion animals, a strong focus on preventive healthcare, stringent regulatory standards, and a high level of pet ownership. European countries have well-established veterinary healthcare systems, with a wide network of veterinary clinics, hospitals, and specialized centers. The region emphasizes the importance of vaccination programs, disease control, and public health concerns related to zoonotic diseases. Additionally, Europe is witnessing advancements in veterinary technology, research collaborations, and investments in innovative treatment modalities, further driving the market growth.

The Asia Pacific region represents a rapidly growing market for veterinary medicine. The region comprises countries such as China, Japan, India, Australia, and emerging economies in Southeast Asia. The market in Asia Pacific is driven by factors such as the increasing disposable income, urbanization, rising pet ownership, and growing demand for animal-derived food products. Asia Pacific has a large population of both companion and production animals, contributing to the demand for veterinary services. The region also witnesses the rising adoption of Western veterinary practices and an increasing focus on animal welfare and preventive healthcare. With the expansion of the middle class and the evolving livestock industry, there is a growing need for advanced veterinary products, diagnostic tools, vaccines, and medications. The market in Asia Pacific is supported by investments in veterinary infrastructure, research and development, and government initiatives promoting animal health and welfare.

Competitive Landscape:

Key players invest significantly in research and development to innovate and introduce new veterinary drugs, vaccines, diagnostic tools, and treatment modalities. R&D efforts focus on enhancing the efficacy, safety, and convenience of veterinary products, as well as developing novel therapies for animal health conditions. Companies collaborate with research institutions and veterinary experts to stay at the forefront of advancements in the field. Additionally, key players strive to expand their product portfolios by acquiring or licensing new products, technologies, or intellectual property rights. This allows them to offer a comprehensive range of veterinary medications, vaccines, diagnostics, nutritional supplements, and other healthcare products. Other than this, key players aim to penetrate new markets and expand their geographic presence to leverage untapped opportunities. This involves establishing partnerships, distribution agreements, or acquiring local companies to gain access to new customer bases and distribution networks. Besides this, key players in the market engage in collaborations and partnerships with veterinary clinics, hospitals, research institutions, and universities. These collaborations aim to drive product development, conduct clinical trials, and expand market reach. Moreover, they invest in marketing and promotional activities to create awareness about their products and services. They employ various channels, including digital marketing, conferences, veterinary events, and educational programs, to reach veterinarians, pet owners, and livestock farmers.

The report has provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

  • Archer-Daniels-Midland Company
  • Boehringer Ingelheim GmbH
  • Cargill Incorporated
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Evonik Industries AG
  • Merck & Co. Inc.
  • Neogen Corporation
  • Vetoquinol S.A.
  • Virbac
  • Zoetis Inc.

Recent Developments:

In April 2022, Elanco Animal Health Incorporated, a leading global animal health company, and Ginkgo Bioworks, the leading horizontal platform for cell programming, announced the launch of BiomEdit, a microbiome innovation company that is expected to discover, develop and introduce novel probiotics, bioactive molecules, engineered microbial medicines and microbial monitoring services for animal health..

Ceva Sante Animale, acquired Artemis Technologies Inc., this strategic move allows Ceva Sante Animale to enhance its portfolio of products dedicated to combating rabies in animals.

Archer-Daniels-Midland Company recently acquired a license for Gnubiotics AMOBIOME, a cutting-edge technology for use in pet food and supplement formulas. Gnubiotics AMOBIOME is a unique prebiotic that targets specific beneficial bacteria in the gut microbiome of animals.

Key Questions Answered in This Report

  • 1.What was the size of the global veterinary medicine market in 2024?
  • 2.What is the expected growth rate of the global veterinary medicine market during 2025-2033?
  • 3.What are the key factors driving the global veterinary medicine market?
  • 4.What has been the impact of COVID-19 on the global veterinary medicine market?
  • 5.What is the breakup of the global veterinary medicine market based on the animal type?
  • 6.What is the breakup of the global veterinary medicine market based on the route of administration?
  • 7.What is the breakup of the global veterinary medicine market based on the distribution channel?
  • 8.What are the key regions in the global veterinary medicine market?
  • 9.Who are the key players/companies in the global veterinary medicine market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Medicine Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Drugs
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Anti-infective
      • 6.1.2.2 Anti-inflammatory
      • 6.1.2.3 Parasiticide
    • 6.1.3 Market Forecast
  • 6.2 Vaccines
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Inactivated Vaccines
      • 6.2.2.2 Attenuated Vaccines
      • 6.2.2.3 Recombinant Vaccines
    • 6.2.3 Market Forecast
  • 6.3 Medicated Feed Additives
    • 6.3.1 Market Trends
    • 6.3.2 Key Segments
      • 6.3.2.1 Amino Acids
      • 6.3.2.2 Antibiotics
    • 6.3.3 Market Forecast

7 Market Breakup by Animal Type

  • 7.1 Production
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Companion
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Route of Administration

  • 8.1 Oral
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Parenteral
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Topical
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Distribution Channel

  • 9.1 Veterinary Hospitals and Clinics
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Point-of-Care Testing/In-house Testing
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Archer-Daniels-Midland Company
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Boehringer Ingelheim GmbH
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Cargill Incorporated
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 SWOT Analysis
    • 15.3.4 Ceva Sante Animale
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dechra Pharmaceuticals PLC
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
    • 15.3.6 Elanco Animal Health Incorporated
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
    • 15.3.7 Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
    • 15.3.8 Merck & Co. Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
    • 15.3.9 Neogen Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Vetoquinol S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
    • 15.3.11 Virbac
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis
    • 15.3.12 Zoetis Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Veterinary Medicine Market: Major Drivers and Challenges
  • Figure 2: Global: Veterinary Medicine Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Veterinary Medicine Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Veterinary Medicine Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Veterinary Medicine Market: Breakup by Animal Type (in %), 2024
  • Figure 6: Global: Veterinary Medicine Market: Breakup by Route of Administration (in %), 2024
  • Figure 7: Global: Veterinary Medicine Market: Breakup by Distribution Channel (in %), 2024
  • Figure 8: Global: Veterinary Medicine Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Veterinary Medicine (Drugs) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Veterinary Medicine (Drugs) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Veterinary Medicine (Vaccines) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Veterinary Medicine (Vaccines) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Veterinary Medicine (Medicated Feed Additives) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Veterinary Medicine (Medicated Feed Additives) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Veterinary Medicine (Production) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Veterinary Medicine (Production) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Veterinary Medicine (Companion) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Veterinary Medicine (Companion) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Veterinary Medicine (Oral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Veterinary Medicine (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Veterinary Medicine (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Veterinary Medicine (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Veterinary Medicine (Topical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Veterinary Medicine (Topical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Veterinary Medicine (Veterinary Hospitals and Clinics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Veterinary Medicine (Veterinary Hospitals and Clinics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Veterinary Medicine (Point-of-Care Testing/In-house Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Veterinary Medicine (Point-of-Care Testing/In-house Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Veterinary Medicine (Other Distribution Channels) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Veterinary Medicine (Other Distribution Channels) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: North America: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: North America: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: United States: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: United States: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Canada: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Canada: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Asia-Pacific: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Asia-Pacific: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: China: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: China: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Japan: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Japan: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: India: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: India: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: South Korea: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: South Korea: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Australia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Australia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: Indonesia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: Indonesia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Europe: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Europe: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Germany: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Germany: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: France: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: France: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: United Kingdom: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: United Kingdom: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: Italy: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: Italy: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: Spain: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: Spain: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Russia: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Russia: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Latin America: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Latin America: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Brazil: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Brazil: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Mexico: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Mexico: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: Others: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: Others: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: Middle East and Africa: Veterinary Medicine Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: Middle East and Africa: Veterinary Medicine Market: Breakup by Country (in %), 2024
  • Figure 79: Middle East and Africa: Veterinary Medicine Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Global: Veterinary Medicine Industry: SWOT Analysis
  • Figure 81: Global: Veterinary Medicine Industry: Value Chain Analysis
  • Figure 82: Global: Veterinary Medicine Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Veterinary Medicine Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Veterinary Medicine Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Veterinary Medicine Market Forecast: Breakup by Animal Type (in Million USD), 2025-2033
  • Table 4: Global: Veterinary Medicine Market Forecast: Breakup by Route of Administration (in Million USD), 2025-2033
  • Table 5: Global: Veterinary Medicine Market Forecast: Breakup by Distribution Channel (in Million USD), 2025-2033
  • Table 6: Global: Veterinary Medicine Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Veterinary Medicine Market: Competitive Structure
  • Table 8: Global: Veterinary Medicine Market: Key Players